patent/US-5273745-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5273745-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f222185b5afdd5953f66cf49ebf48167
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	1989-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	1993-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62fe7a956af60d3f7a9fd6c8471116c4
publicationDate	1993-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	US-5273745-A
titleOfInvention	Virus-modified tumor vaccines for immunotherapy of tumor metastases
abstract	The invention discloses a virus-modified tumour-specific vaccine consisting of corresponding separated tumour cells inactivated by irradiation and incubated with NDV (Newcastle Disease Virus) under sterile conditions in serum-free medium. The vaccine may optionally be irradiated again prior to application.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040094635-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011206736-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004208849-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8147822-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329881-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006216310-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009081161-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003165465-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9814206-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004170607-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7736640-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010196408-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129446-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377450-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7780962-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7598229-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9144603-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0209747-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003044384-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056689-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009220461-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283266-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004141990-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057037-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6555372-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105578-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009060946-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8043612-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10251922-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308913-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6406689-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166287-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7470426-B1
priorityDate	1988-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227259725 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6454976

Total number of triples: 58.